Focus |

Humans 2.0

Increasingly powerful genetic technologies are moving us closer to the ability to read and manipulate human genomes not only in somatic cells, but also in germ cells and  zygotes. This focus looks at how these technologies are impacting human embryo research and how this may ultimately affect our lives and offspring.


Of the germline engineering approaches, mitochondrial replacement, rather than gene editing, is poised to have the greatest impact on our lives.

Editorial | | Nature Biotechnology

As the technology to create genetically modified babies moves closer to practice, what questions should we ask before such procedures are contemplated? Amber Dance investigates.

News Feature | | Nature Biotechnology

Mitochondrial replacement therapy is being touted as a means of combating maternally inherited disease. But concerns are growing about mitochondrial reversion compromising cures. Steve Connor investigates.

News Feature | | Nature Biotechnology

Finding partners through DNA profiles has yet to catch on, but the commercial sector for preconception and prenatal testing is booming. Malorye Allison Branca reports.

News Feature | | Nature Biotechnology

A group of interdisciplinary delegates drawn from the top biotech-producing countries of the world offers a consensus statement outlining a set of principles important to consider in the ethical conversation about human cellular biotechnological research moving forward.

Perspective | | Nature Biotechnology